Parathyroid hormone is associated with prostate cancer

Prostate International - Tập 8 - Trang 116-120 - 2020
Won Tae Kim1,2, Woo Jin Bang1,3, Sung Pil Seo2, Ho Won Kang2, Young Joon Byun1, Xuan-Mei Piao1, Pildu Jeong1, Kyung-Sub Shin4, Song-Yi Choi5, Ok-Jun Lee6, Yong-June Kim1,2, Sang Cheol Lee1,2, Seok Joong Yun1,2, Wun-Jae Kim1,2
1Department of Urology, Chungbuk National University College of Medicine, Cheongju, Korea
2Department of Urology, Chungbuk National University Hospital, Cheongju, Korea
3Department of Urology, Hanllym University College of Medicine, Chuncheon, Korea
4Department of Laboratory Medicine, College of Medicine, National University, Cheongju, Chungbuk, Korea
5Department of Pathology, College of Medicine, Chungnam National University, Daejeon, Korea
6Department of Pathology, Chungbuk National University College of Medicine, Cheongju, Korea

Tài liệu tham khảo

Siegel, 2019, Cancer statistics, CA Cancer J Clin, 69, 7, 10.3322/caac.21551 Sim, 2005, Changing demography of prostate cancer in Asia, Eur J Canc, 41, 834, 10.1016/j.ejca.2004.12.033 Jung, 2019, Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2016, Cancer Res Treat, 51, 417, 10.4143/crt.2019.138 Song, 2015, Incidence of kidney, bladder, and prostate cancers in Korea: An update, Korean J Urol, 56, 422, 10.4111/kju.2015.56.6.422 Schwartz, 1990, Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis), Anticancer Res, 10, 1307 Schwartz, 1997, 1 alpha,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells, Cancer Epidemiol Biomarkers Prev, 6, 727 Brändstedt, 2012, Vitamin D, PTH, and calcium and the risk of prostate cancer: a prospective nested case-control study, Cancer Causes Control, 23, 1377, 10.1007/s10552-012-9948-3 Ritchie, 1997, Effects of the calciotrophic peptides calcitonin and parathyroid hormone on prostate cancer growth and chemotaxis, Prostate, 30, 183, 10.1002/(SICI)1097-0045(19970215)30:3<183::AID-PROS6>3.0.CO;2-N Skinner, 2008, Serum calcium and incident and fatal prostate cancer in the National Health and Nutrition Examination Survey, Cancer Epidemiol Biomarkers Prev, 17, 2302, 10.1158/1055-9965.EPI-08-0365 Albanes, 2011, Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study, Cancer Epidemiol Biomarkers Prev, 20, 1850, 10.1158/1055-9965.EPI-11-0403 Sawada, 2017, Plasma 25-hydroxy vitamin D and subsequent prostate cancer risk in a nested Case-Control study in Japan: The JPHC study, Eur J Clin Nutr, 71, 132, 10.1038/ejcn.2016.184 Schwartz, 2008, Prostate cancer, serum parathyroid hormone, and the progression of skeletal metastases, Cancer Epidemiol Biomarkers Prev, 17, 478, 10.1158/1055-9965.EPI-07-2747 Murray, 2001, Hypocalcemic and normocalcemic hyperparathyroidism in patients with advanced prostatic cancer, J Clin Endocrinol Metab, 86, 4133, 10.1210/jcem.86.9.7864 Quirosa Flores, 2010, Secondary hyperthyroidism in advanced prostate cancer, Endocriol Nutr, 57, 100, 10.1016/j.endonu.2010.01.013
Thông tin
Thông tin xuất bản

Prostate International

Tập 8

116-120

Thông tin tác giả